| Literature DB >> 24002356 |
Takashi Honda1, Keiichi Itatani, Manabu Takanashi, Eri Mineo, Atsushi Kitagawa, Hisashi Ando, Sumito Kimura, Yayoi Nakahata, Norihiko Oka, Kagami Miyaji, Masahiro Ishii.
Abstract
Flow energy loss (EL) at the Fontan anastomosis has been thought to reflect flow efficiencies and to influence on hemodynamics in the Fontan circulation and has been often discussed in numerical studies. However, in vivo EL measurements have to date not been reported. We directly measured EL in the Fontan circulation and examined the relationship between the structural configuration and EL, as well as the influence of EL, on the hemodynamics in the Fontan circulation. We performed a catheterization study measuring simultaneous pressure and flow velocity to calculate EL in nine patients (mean age 2.3 ± 0.3 years) 1 year after the Fontan procedure. The measured EL was 9.66 ± 8.50 mW. One patient with left pulmonary artery stenosis recorded the highest EL (17.78 mW), and one patient with bilateral superior vena cava and left phrenic nerve palsy recorded the second highest EL (14.62 mW). EL significantly correlated with time constant tau and weakly with max-dp/dt during the isovolumic diastolic phase (r = 0.795 and -0.574, respectively). EL also correlated with max-dp/dt during the isovolumic systolic phase (r = 0.842) but not with ejection fraction or systemic blood flow (r = 0.384 and -0.034, respectively). In conclusion, inefficient structural configuration and phrenic nerve palsy seem to be related with increased in EL at the Fontan anastomosis. Although these preliminary findings also suggest that EL is associated with an impaired relaxation of the ventricle, a long-term study with a large population is warranted to reach such a definitive conclusion.Entities:
Mesh:
Year: 2013 PMID: 24002356 PMCID: PMC3897874 DOI: 10.1007/s00246-013-0783-4
Source DB: PubMed Journal: Pediatr Cardiol ISSN: 0172-0643 Impact factor: 1.655
Patient characteristics
| Patient no. | Disease | Age at operation (month) | Age at catheterization (month) | Sex | Main ventricle | Procedure | EL (mW) | Complication | Medication |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DORV, HLV | 16 | 31 | F | R | LT | 8.46 | None | ACEI, sildenafil |
| 2 | SV, SA | 15 | 27 | M | L | Intra-atrial conduit | 14.62 | Bilateral SVC, phrenic nerve palsy | ACEI, diuretic, digitalis |
| 3 | DORV, HLV | 14 | 25 | M | R | Extracardiac TCPC | 5.47 | None | None |
| 4 | HLHS | 19 | 33 | F | R | Extracardiac TCPC | 17.78 | LPA stenosis | ACEI, diuretic, β-blocker, digitalis |
| 5 | SV, SA | 12 | 24 | F | R | Extracardiac TCPC | 10.48 | None | Diuretic, digitalis |
| 6 | SV, PA-IVS, TA | 13 | 25 | M | L | Extracardiac TCPC | 6.32 | None | Diuretic |
| 7 | TGA(II), HRV | 12 | 24 | M | L | Extracardiac TCPC | 7.93 | None | None |
| 8 | PA-IVS, HRV | 15 | 29 | F | L | Extracardiac TCPC | 10.67 | None | ACEI, sildenafil |
| 9 | HLHS | 15 | 29 | M | R | Extracardiac TCPC | 5.26 | None | None |
ACEI angiotensin-converting enzyme inhibitor, DORV double-outlet right ventricle, EL energy loss, HLHS hypoplastic left heart syndrome, HLV hypoplastic left ventricle, HRV hypoplastic right ventricle, LPA left pulmonary artery, LT lateral tunnel, PA-IVS pulmonary atresia with intact ventricular septum, SA single atrium, SV single ventricle, SVC superior vena cava, TA tricuspid valve atresia, TCPC total cavopulmonary connection, TGA complete transposition of the great arteries
Fig. 1Catheterization method. Intravascular pressure and doppler flow velocity were simultaneously measured at the SVC, the IVC, the RPA, and the LPA
Correlations between EL and cardiac functional parameters
| Parameter | EL | EL/inlet energy | ||
|---|---|---|---|---|
| r |
|
|
| |
| Inlet energy | –0.214 | NS | –0.658 | NS |
| Sdpdt | 0.842 | 0.004 | 0.764 | 0.016 |
| Ddpdt | –0.574 | NS | –0.360 | NS |
| Time constant tau | 0.795 | 0.010 | 0.868 | 0.002 |
| EF | 0.385 | NS | 0.0252 | NS |
| EDP | –0.628 | NS | –0.398 | NS |
| PAWP | –0.537 | NS | –0.240 | NS |
| CVP | –0.004 | NS | 0.175 | NS |
| Qp | 0.070 | NS | 0.109 | NS |
| Qs | –0.034 | NS | –0.060 | NS |
| PVR | 0.132 | NS | 0.028 | NS |
| SVR | –0.190 | NS | –0.006 | NS |
| SaO2 | –0.346 | NS | 0.135 | NS |
| SvO2 | –0.005 | NS | 0.135 | NS |
CVP central venous pressure, Ddpdt the max-dp/dt during the isovolumic diastolic phase, EDP end diastolic pressure, EF ejection fraction, EL flow energy loss, NS non-significant, PAWP pulmonary artery wedge pressure, PVR pulmonary vascular resistance, Qp pulmonary blood flow, SaO hemoglobin oxygen saturation, Qs systemic blood flow, Sdpdt max dp/dt during the isovolumic systolic phase, SpO arterial oxygen saturation, SvO venous oxygen saturation, SVR systemic vascular resistance
Fig. 2Relationship between ventricular diastolic and systolic function and EL. a EL was significantly correlated with time constant tau (r = 0.795). b EL was weakly correlated with max-dp/dt during Ddpdt (r = −0.574). c EL was not correlated with EDP (r = −0.313). d EL was significantly correlated with max-dp/dt during Sdpdt (r = 0.842). e EL was not correlated with EF (r = 0.384). f EL was not correlated with Qs (r = –0.034)